soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Read the full at NEJM.org (link in bio). ⁣ ⁣ #ACC25 #Cardiology #ClinicalTrials #NEJM 💊 Semaglutide — the active

Our licensed providers meet you online, wherever you are in Florida, to create a personalized plan that supports your health goals with compassion and clarity

If youre an adult with a BMI of at least 30 or a BMI of 27 or higher with a weight-related condition such as high blood pressure, semaglutide could be an excellent option

Restarting is a medically appropriate response to a chronic condition

Form Matters : Not all types of L-Carnitine absorb the same way

AM833 is a novel agonist of calcitonin family G protein-coupled receptors: Pharmacological comparison with six selective and nonselective agonists

While some studies suggest potential benefits for pigmentation management, outcomes can differ among individuals, and long-term high-dose effects remain under evaluation